Naringenin more effectively inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in macrophages

Chia-Lun Chao1, Ching-Sung Weng, Nen-Chung Chang

  • 1Division of Cardiology, Department of Internal Medicine, Taoyuan General Hospital, Department of Health, Executive Yuan, 33004 Taoyuan, Taiwan.

Insights

Naringenin, a flavonoid, effectively reduces inflammation in macrophages and microglia, crucial in conditions like heart attack and stroke. It shows greater anti-inflammatory effects in macrophages, suggesting potential benefits for cardiovascular and cerebrovascular health.

Area of Science:

  • Biochemistry and Molecular Biology
  • Immunology
  • Pharmacology

Background:

  • Macrophages and microglia are key players in the initial stages of acute myocardial infarction and ischemic stroke.
  • The comparative anti-inflammatory effects of naringenin on these cells, particularly in response to lipopolysaccharide (LPS), were not fully elucidated.
  • Naringenin, a flavonoid, was investigated for its potential to modulate inflammatory responses in these critical immune cells.

Purpose of the Study:

  • To compare the anti-inflammatory efficacy of naringenin on LPS-stimulated macrophages and microglia.
  • To determine the dose-dependent inhibitory effects of naringenin on nitrite production and key inflammatory markers.
  • To compare the anti-inflammatory potential of naringenin with Vitamin C in these cellular models.

Main Methods:

  • Utilized RAW 264.7 macrophages and BV2 microglia cell lines stimulated with lipopolysaccharide (LPS).
  • Assessed cell viability, nitrite production, and expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2).
  • Compared the effects of varying concentrations of naringenin and a fixed concentration of Vitamin C.

Main Results:

  • Naringenin demonstrated dose-dependent inhibition of nitrite production and iNOS/COX-2 expression in both cell types under LPS stimulation.
  • Macrophages exhibited higher viability at elevated naringenin concentrations and were more sensitive to LPS activation compared to microglia.
  • Naringenin showed a broader effective concentration range and lower effective concentrations in macrophages (50 μmol/L) versus microglia (100 μmol/L).

Conclusions:

  • Naringenin is a potent inhibitor of LPS-induced inflammation in macrophages and microglia, with superior efficacy observed in macrophages.
  • Vitamin C (100 μmol/L) exhibited less suppression of nitrite production than naringenin (100 μmol/L) in macrophages and microglia.
  • Dietary intake of naringenin-rich flavonoids may offer protective benefits against inflammatory processes in cardiovascular and cerebrovascular diseases.